Trial Registration
SECONDARY
ClinicalTrials.gov Identifier: This prespecified secondary analysis of a randomized clinical trial assesses the long-term posttrial risk of morbidity and mortality outcomes among participants who were randomized to a thiazide-type diuretic, calcium channel blocker, or ACE inhibitor with up to 23 years of follow-up.